Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP‐43 pathology
Barış Genç, Mukesh Gautam, Öge Gözütok, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Molecular mechanism of selenium against lead-induced apoptosis in chicken brainstem relating to heat shock protein, selenoproteins, and inflammatory cytokines
Dechun Chen, Weikang Yu, Zhiyu Hao, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 272, pp. 116028-116028
Open Access | Times Cited: 18
Ultrasound–enhanced brain delivery of edaravone provides additive amelioration on disease progression in an ALS mouse model
Yuanyuan Shen, Ji Zhang, Yiluo Xu, et al.
Brain stimulation (2023) Vol. 16, Iss. 2, pp. 628-641
Closed Access | Times Cited: 22
The glymphatic system and Amyotrophic lateral sclerosis
Andrew Eisen, Maiken Nedergaard, E. G. Gray, et al.
Progress in Neurobiology (2024) Vol. 234, pp. 102571-102571
Closed Access | Times Cited: 8
SBT-272 improves TDP-43 pathology in ALS upper motor neurons by modulating mitochondrial integrity, motility, and function
Mukesh Gautam, Barış Genç, Benjamin Helmold, et al.
Neurobiology of Disease (2023) Vol. 178, pp. 106022-106022
Open Access | Times Cited: 15
SuanZaoRen decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1/Nrf2 signaling pathway
Qinghua Long, T. T. Li, Qihang Zhu, et al.
Journal of Ethnopharmacology (2023) Vol. 323, pp. 117679-117679
Open Access | Times Cited: 13
Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases
Elizabeth A. Johnson, Raghad Nowar, Kirsten L. Viola, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access
Drug Combination to Slow Down the Progression of Amyotrophic Lateral Sclerosis
Myriam Torres-Rico, Borja Marín-Rodríguez, Miriam Samira Arasmou-Idrovo, et al.
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy
Mukesh Gautam, Aksu Günay, Navdeep S. Chandel, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
High-density multielectrode arrays bring cellular resolution to neuronal activity and network analyses of corticospinal motor neurons
Christopher A. Quintanilla, Zachary Fitzgerald, Omar Kashow, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Structural insights and milestones in TDP-43 research: A comprehensive review of its pathological and therapeutic advances
Mei Dang, Longjiang Wu, Xiaoying Zhang
International Journal of Biological Macromolecules (2025), pp. 141677-141677
Open Access
Pthology reduction and motor behavior improvement associated with ultrasound-mediated delivery of arctiin to the motor cortex in a mutant SOD1 mouse model of amyotrophic lateral sclerosis
Ji Zhang, Kaili Chen, Yizhe Chen, et al.
Ultrasonics (2024) Vol. 144, pp. 107449-107449
Closed Access | Times Cited: 3
Altered synaptic currents, mitophagy, mitochondrial dynamics in Alzheimer's disease models and therapeutic potential of Dengzhan Shengmai capsules intervention
Binbin Zhao, Dongfeng Wei, Qinghua Long, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 3, pp. 348-370
Open Access | Times Cited: 8
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
Peter J. Richardson, Daniel P. Smith, Alex de Giorgio, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
Luis F. González, Lorenzo E. Bevilacqua, Rodrigo Naves
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2055-2055
Open Access | Times Cited: 16
NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
Barış Genç, Mukesh Gautam, Benjamin Helmold, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis
Mohamed F. El‐Mansy, Cory T. Reidl, Mizzanoor Rahaman, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2260-2302
Open Access | Times Cited: 6
Accumulation of Nonfibrillar TDP-43 in the Rough Endoplasmic Reticulum Is the Early-Stage Pathology in Amyotrophic Lateral Sclerosis
Tomoya Kon, Fumiaki Mori, Kunikazu Tanji, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 4, pp. 271-281
Open Access | Times Cited: 10
Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons
Barış Genç, Javier H. Jara, Santana S. Sanchez, et al.
Gene Therapy (2021) Vol. 29, Iss. 3-4, pp. 178-192
Open Access | Times Cited: 14
Effect of eIF2α in Neuronal Injury Induced by High Glucose and the Protective Mechanism of Resveratrol
Lijing Zhang, Kaining Zhi, Yanfang Su, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 6043-6059
Closed Access | Times Cited: 5
CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis
Aya Ikeda, Hongrui Meng, Daisuke Taniguchi, et al.
PNAS Nexus (2024) Vol. 3, Iss. 8
Open Access | Times Cited: 1
Ginsenoside-Rg1 combined with a conditioned medium from induced neuron-like hUCMSCs alleviated the apoptosis in a cell model of ALS through regulating the NF-κB/Bcl-2 pathway
Yu Huang, Huili YANG, Biying Yang, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 7, pp. 540-550
Closed Access | Times Cited: 2
Conditional deletion of MAD2B in forebrain neurons enhances hippocampus-dependent learning and memory in mice
Li Cheng, Yanfang Su, Kaining Zhi, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 3
Primary lateral sclerosis natural history study – planning, designing, and early enrollment
Hiroshi Mitsumoto, Grace E. Jang, Ik Jae Lee, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2022) Vol. 24, Iss. 5-6, pp. 394-404
Closed Access | Times Cited: 3
Targeting MAD2B as a strategy for ischemic stroke therapy
L X Zhang, Hengzhen Cui, Wandi Hu, et al.
Journal of Advanced Research (2024)
Open Access
Page 1 - Next Page

Scroll to top